These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
4. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W, Matthias T, Scharrer I. Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [Abstract] [Full Text] [Related]
5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J. Verh K Acad Geneeskd Belg; 2000 Jun; 62(5):353-72. PubMed ID: 11144685 [Abstract] [Full Text] [Related]
6. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related]
7. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome]. Ieko M, Nakabayashi T, Tarumi T, Yoshida M, Naito S, Atsumi T, Koike T. Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574 [Abstract] [Full Text] [Related]
11. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name? Harris EN, Pierangeli SS. Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301 [Abstract] [Full Text] [Related]
12. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A. Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [Abstract] [Full Text] [Related]
14. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Horbach DA, van Oort E, Donders RC, Derksen RH, de Groot PG. Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011 [Abstract] [Full Text] [Related]
15. [Primary antiphospholipid syndrome]. Popa A, Voinea L, Pop M, Stana D, Dascalu AM, Alexandrescu C, Ciuluvica R. Oftalmologia; 2008 Dec; 52(1):13-7. PubMed ID: 18714484 [Abstract] [Full Text] [Related]
16. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I, Levi Y, Godard G, Shoenfeld Y. Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [Abstract] [Full Text] [Related]
18. [Antiphospholipid syndrome diagnosis: an update]. Visseaux B, Masliah-Planchon J, Fischer AM, Darnige L. Ann Biol Clin (Paris); 2011 Jun; 69(4):411-8. PubMed ID: 21896405 [Abstract] [Full Text] [Related]
19. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies]. Barbui T, Finazzi G, Galli M. Ann Ital Med Int; 1997 Jun; 12(2):76-83. PubMed ID: 9333316 [Abstract] [Full Text] [Related]
20. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T. Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348 [Abstract] [Full Text] [Related] Page: [Next] [New Search]